周五盘中，Amphastar制药（股票代码：AMPH）股价大幅上涨11.79%，引起投资者广泛关注。这一显著涨幅主要源于公司发布的最新季度财报优于市场预期。
根据公司公告，截至2025年6月30日的季度调整后每股收益达到0.85美元，显著高于分析师平均预期的0.74美元。尽管公司营收同比下降4.4%至1.7441亿美元，但仍略微超过了华尔街1.7334亿美元的预期。这一强劲的业绩表现，特别是在盈利能力方面的显著改善，成为推动股价上涨的主要因素。
值得注意的是，在此次财报公布之前，Amphastar制药的股价今年以来已下跌43.9%。此次积极的财报结果可能标志着公司业务转折点的到来。分析师对公司前景保持乐观，目前对该股的平均评级为"买入"，12个月目标价中位数为32.50美元，较最近收盘价有约33.5%的上涨空间。这一乐观展望可能进一步支撑了投资者的信心，推动股价强劲反弹。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.